VEYVONDI 1300 IU powder and solvent for solution for injection., ADVATE 1000 IU powder and solvent for solution for injection., VEYVONDI 650 IU powder and solvent for solution for injection., ADVATE 500 IU powder and solvent for solution for injection.
071102
Phase 3 small_molecule active
Quick answer
VEYVONDI 1300 IU powder and solvent for solution for injection., ADVATE 1000 IU powder and solvent for solution for injection., VEYVONDI 650 IU powder and solvent for solution for injection., ADVATE 500 IU powder and solvent for solution for injection. for Hereditary severe von Willebrand Disease in children is a Phase 3 program (small_molecule) at Baxalta Innovations GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Baxalta Innovations GmbH
- Indication
- Hereditary severe von Willebrand Disease in children
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active